36-month cost-utility analysis of antipsychotic treatments in patients with schizophrenia in the pan-European soho (schizophrenia outpatient health outcomes) study

被引：0
|
作者：
Windmeijer, F.
Brown, J.
Novick, D.
Hong, J.
Knapp, M.
Kontodimas, S.
Ratcliffe, M.
机构：
[1] Univ Bristol, Lilly Res Ctr Ltd, Bristol GU20 6PH, England
[2] Eli Lilly & Co, Windlesham, Surrey, England
[3] London Sch Econom, London, England
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68776-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A78 / A79
页数：2
相关论文
共 50 条
  • [1] 12 month cost-utility analysis of oral antipsychotic treatments in patients with schizophrenia in the pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Knapp, M
    Windmeijer, F
    Haro, JM
    Kontodimas, S
    Brown, J
    Tzivelekis, S
    Novick, D
    Ratcliffe, M
    VALUE IN HEALTH, 2005, 8 (06) : A205 - A205
  • [2] 12-month cost-effectiveness analysis of oral antipsychotic treatments in patients with schizophrenia in the pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Knapp, M
    Windmeijer, F
    Haro, JM
    Kontodimas, S
    Brown, J
    Tzivelekis, S
    Novick, D
    Ratcliffe, M
    VALUE IN HEALTH, 2005, 8 (06) : A204 - A204
  • [3] Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study
    Knapp, Martin
    Windmeijer, Frank
    Brown, Jacqueline
    Kontodimas, Stathis
    Tzivelekis, Spyridon
    Haro, Josep Maria
    Ratcliffe, Mark
    Hong, Jihyung
    Novick, Diego
    PHARMACOECONOMICS, 2008, 26 (04) : 341 - 358
  • [4] Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study
    Martin Knapp
    Frank Windmeijer
    Jacqueline Brown
    Stathis Kontodimas
    Spyridon Tzivelekis
    Josep Maria Haro
    Mark Ratcliffe
    Jihyung Hong
    Diego Novick
    PharmacoEconomics, 2008, 26 : 341 - 358
  • [5] The cost of relapse in patients with schizophrenia in the pan-European SOHO (Schizophrenia outpatient health outcomes) study
    Brown, J
    Zhu, G
    Diego, N
    Suarez, D
    Haro, JM
    Windmeijer, F
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 124S - 124S
  • [6] The cost of relapse in patients with schizophrenia in the pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Zhu, G
    Brown, J
    Novick, D
    Suarez, D
    Haro, JM
    Windmeijer, F
    VALUE IN HEALTH, 2006, 9 (03) : A75 - A75
  • [7] Tolerability of outpatient antipsychotic treatment:: 36-Month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, D.
    Haro, J. M.
    Suarez, D.
    Bushe, C.
    Lepine, J. P.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S161 - S161
  • [8] Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Novick, Diego
    Maria Haro, Josep
    Perrin, Elena
    Suarez, David
    Texeira, Joao Marques
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (08) : 542 - 550
  • [9] Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Haro, JM
    Edgell, ET
    Novick, D
    Alonso, J
    Kennedy, L
    Jones, PB
    Ratcliffe, M
    Breier, A
    ACTA PSYCHIATRICA SCANDINAVICA, 2005, 111 (03) : 220 - 231
  • [10] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the pan-European SOHO (schizophrenia outpatient health outcomes) study
    Haro, J
    Novick, D
    Belger, M
    Tzivelekis, S
    Murray, D
    Texeira, JM
    Alonso, J
    Bousono, MG
    Gasquet, I
    Kristensen, H
    Jones, PB
    Croudace, T
    Knapp, M
    Lepine, JP
    Mavreas, V
    Naber, D
    Pancheri, P
    Slooff, CJ
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 486 - 486
12345